Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fuller

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomiaJianzhong Cao, Xiaodong Zhang, Bo Jiang, et al.
Clinical and Translational Radiation Oncology|August 25, 2021
Factors associated with complex oral treatment device usage in patients with head and neck cancerStephen Palasi, Ning Zhang, Mikaela Bankston, et al.
Acta Oncologica (Stockholm, Sweden)|January 21, 2022
The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patientsSonja Stieb, Grete M Engeseth, Abdallah S R Mohamed, et al.
Acta Oncologica (Stockholm, Sweden)|October 4, 2014
Auto-segmentation of the brachial plexus assessed with TaCTICS - a software platform for rapid multiple-metric quantitative evaluation of contoursMusaddiq Awan, Brandon Alan Dyer, Jayashree Kalpathy-Cramer, et al.
International Journal of Computer Assisted Radiology and Surgery|December 6, 2014
Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapyJared D Sturgeon, John A Cox, Lauren L Mayo, et al.
Plos One|October 15, 2013
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancerHernan Roca, James Hernandez, Savannah Weidner, et al.
Frontiers in Oncology|June 20, 2022
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED)Thiru Prasanna, Laeeq Malik, Robert D McCuaig, et al.
Cancers|February 25, 2022
Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical TrialsRoshal R Patel, Rose Parisi, Vivek Verma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapyAlexander F Bagley, Rong Ye, Adam S Garden, et al.
BMC Cancer|June 13, 2021
Food and Drug Administration approvals in phase 3 Cancer clinical trialsJoseph Abi Jaoude, Ramez Kouzy, Marc Ghabach, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomiaJianzhong Cao, Xiaodong Zhang, Bo Jiang, et al.
Clinical and Translational Radiation Oncology|August 25, 2021
Factors associated with complex oral treatment device usage in patients with head and neck cancerStephen Palasi, Ning Zhang, Mikaela Bankston, et al.
Acta Oncologica (Stockholm, Sweden)|January 21, 2022
The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patientsSonja Stieb, Grete M Engeseth, Abdallah S R Mohamed, et al.
Acta Oncologica (Stockholm, Sweden)|October 4, 2014
Auto-segmentation of the brachial plexus assessed with TaCTICS - a software platform for rapid multiple-metric quantitative evaluation of contoursMusaddiq Awan, Brandon Alan Dyer, Jayashree Kalpathy-Cramer, et al.
International Journal of Computer Assisted Radiology and Surgery|December 6, 2014
Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapyJared D Sturgeon, John A Cox, Lauren L Mayo, et al.
Plos One|October 15, 2013
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancerHernan Roca, James Hernandez, Savannah Weidner, et al.
Frontiers in Oncology|June 20, 2022
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED)Thiru Prasanna, Laeeq Malik, Robert D McCuaig, et al.
Cancers|February 25, 2022
Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical TrialsRoshal R Patel, Rose Parisi, Vivek Verma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapyAlexander F Bagley, Rong Ye, Adam S Garden, et al.
BMC Cancer|June 13, 2021
Food and Drug Administration approvals in phase 3 Cancer clinical trialsJoseph Abi Jaoude, Ramez Kouzy, Marc Ghabach, et al.
Pageof 20